Document Detail

Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
MedLine Citation:
PMID:  15706466     Owner:  NLM     Status:  MEDLINE    
Side effects from a high-dose clozapine treatment for a schizophrenic patient led to massive compliance problems. The dose of clozapine could be halved without recurrence of an acute psychotic symptomatology by concomitantly administering amisulpride. The side effects, especially hypersalivation, disappeared almost entirely, which in turn led to good compliance. In a short review we would like to present the pathophysiology and therapeutic options of clozapine-induced hypersalivation.
B Croissant; D Hermann; R Olbrich
Related Documents :
1269876 - Piperazine hepatitis.
10110876 - Review effect on cost reports: impact smaller than anticipated.
17905186 - Premedication for tracheal intubation in neonates: confusion or controversy?
24111706 - Development of anterior inferior cerebellar artery pseudoaneurysm after gamma knife sur...
5571836 - The importance of group b streptococci as human pathogens in the british isles.
23515556 - A case of concomitant occurrence of solitary fibrous tumor and urothelial high-grade in...
Publication Detail:
Type:  Case Reports; Letter    
Journal Detail:
Title:  Pharmacopsychiatry     Volume:  38     ISSN:  0176-3679     ISO Abbreviation:  Pharmacopsychiatry     Publication Date:  2005 Jan 
Date Detail:
Created Date:  2005-02-11     Completed Date:  2005-05-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8402938     Medline TA:  Pharmacopsychiatry     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  38-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antipsychotic Agents / administration & dosage,  adverse effects*,  therapeutic use
Clozapine / administration & dosage,  adverse effects*,  therapeutic use
Drug Therapy, Combination
Schizophrenia, Paranoid / drug therapy,  psychology
Sialorrhea / chemically induced*
Sulpiride / administration & dosage,  adverse effects*,  analogs & derivatives*,  therapeutic use
Reg. No./Substance:
0/Antipsychotic Agents; 15676-16-1/Sulpiride; 53583-79-2/sultopride; 5786-21-0/Clozapine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Jap...
Next Document:  Laboratory detection of inherited thrombophilia: a historical perspective.